OSE Immunotherapeutics Receives European Patent Notice of Allowance for First-in-Class CD28-Antagonist Immunotherapy FR104

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability